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ABSTRACT
Autologous adipose tissue transplantation is clinically used to reduce dermal
scarring and to restore volume loss. The therapeutic benefit on tissue damage
more likely depends on the stromal vascular fraction of adipose tissue than on
the adipocyte fraction. This stromal vascular fraction can be obtained by
dissociation of adipose tissue, either enzymatically or mechanical. Enzymatic
dissociation procedures are time-consuming and expensive. Therefore, we
developed a new inexpensive mechanical dissociation procedure to obtain the
stromal vascular fraction from adipose tissue in a time sparing way, which is
directly available for therapeutic injection. This mechanical dissociation
procedure is denoted as the fractionation of adipose tissue (FAT) procedure. The
FAT procedure was performed in eleven patients. The composition of the FAT-
stromal vascular fraction was characterized by immunohistochemistry. Adipose
derived stromal cells isolated from the FAT-stromal vascular fraction were
compared with adipose derived stromal cells isolated from nondissociated
adipose tissue (control) for their CD-surface marker expression, differentiation
and colony forming unit capacity. Case reports demonstrated the therapeutic
effect of the FAT-stromal vascular fraction. The FAT-stromal vascular fraction is
an enrichment of extracellular matrix containing a microvasculature and
culturable adipose derived stromal cells. Adipose derived stromal cells isolated
from FAT-stromal vascular fraction did not differ from adipose derived stromal
cells isolated from the control group in CD-surface marker expression,
differentiation and colony forming unit capacity. The FAT procedure is a rapid
effective mechanical dissociation procedure to generate FAT-stromal vascular
fraction ready for injection with all its therapeutic components of adipose tissue:
it contains culturable adipose derived stromal cells embedded in their natural
supportive extracellular matrix together with the microvasculature.
Nowadays, autologous adipose tissue transplantation is fre-
quently used to reduce dermal scarring1,2 and to restore
volume loss3 as is the case with soft tissue defects, facial
fat atrophy4,5 and ageing of the face.6 The therapeutic ben-
efit of autologous adipose tissue transplantation in these
aforementioned situations is partly ascribed to the presence
of precursors of adipose derived stromal cells (ASC) in
this autologous adipose tissue albeit that this awaits formal
proof. ASC are progenitor cells that reside in the stromal
vascular fraction (SVF) of adipose tissue attached around
the vessels as pericytes and periadventitial cells.7,8 In vitro,
these precursors readily adhere to tissue culture plastic
after their enzymatic dissociation from other cells in the
SVF. During culture, the typical ASC phenotype emerges,
e.g., the secretion of a plethora of growth factors, cyto-
kines, matrix proteases, and extracellular matrix (ECM)
molecules.9 Furthermore, these cells are able to differenti-
ate into ectodermal,10 endodermal,11 or mesenchymal cell-
lineages.12 Therefore, ASC seem to be suitable for cell-
based therapy to repair damaged tissue in organs and aged
skin.13 For example, in cardiology ASC are already used
for the clinical experimental treatment of ischemic cardio-
myopathy14 to repair heart muscle cells, in orthopedics
ASC are used to treat intervertebrate disc degeneration15
and in cosmetic facial surgery ASC are reported to be ben-
eficial for skin rejuvenation.16
The SVF of adipose tissue comprises all nonadipocyte
cells, e.g., fibroblasts, leukocytes, endothelial cells, and the
connecting ECM.17 As a whole, the SVF potentially har-
bors more therapeutic capacity than the ASC alone: the
ECM can augment tissue remodeling, because it acts as a
temporary scaffold that also contains matrix remodeling
enzymes and because it serves as a slow-release reservoir
of growth factors. Moreover, the fragmented microvascula-
ture may augment reperfusion after injection of SVF.18–21
Therefore, it would be ideal to harvest this SVF fraction as
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an intact and injectable “unit” to be used in a more spe-
cific way such as in cell-based therapy. This SVF can be
isolated from adipose tissue either by means of enzymatic
dissociation or by means of mechanical dissociation. Most
enzymatic techniques used thus far for isolating the SVF
from adipose tissue use collagenase.22 Main disadvantage
of all these enzymatic techniques is that they are rather
time-consuming and expensive, but also that enzymatic
treatment disrupts all communicative connections that exist
between the cells as well as between the cells and ECM.
Moreover, legislation in several countries does not allow
to clinically apply cell-based products that are derived
with collagenase.
Mechanical dissociation of adipose tissue to isolate the
SVF, however, might be more suitable as compared to
enzymatic dissociation, because mechanical dissociation of
adipose tissue is a fast time sparing inexpensive method.
In this study, we describe a new method to mechanically
dissociate adipose tissue intraoperatively to get hold of its
therapeutic components for injection: this procedure is
named the fractionation of adipose tissue (FAT) procedure.
MATERIALS AND METHODS
Liposuction and FAT procedure
Adipose tissue harvesting was performed with a Sorenson
lipo-harvesting cannula (Tulip, Medical Products, San
Diego, CA) during normal liposuction procedures in eleven
patients (Figure S1, Supporting Information). Adipose tissue
was harvested after infiltration with 500 mL-modified
Klein’s solution (per 500 mL of saline, 20 mL of lidocaine,
2% Epinefrine 1 : 200.000 and 2 mL of bicarbonate was
added). For the FAT procedure, harvested adipose tissue
was centrifuged at 3,000 rpm with a 9.5 cm radius fixed
angle rotor for 2.5 minutes (Medilite, Thermo Fisher Scien-
tific, Waltham, MA) at room temperature (RT) after decan-
tation. After one round of centrifugation, the oil and
infiltration fluid fractions were discarded, yielding con-
densed lipoaspirate. One sample of 10 mL of condensed lip-
oaspirate that was centrifuged only once was used as a
control, from heron referred as “control.” One sample of
10 mL of condensed lipoaspirate was used for mechanical
dissociation. For mechanical dissociation, two 10 mL syrin-
ges with a total volume of 10 mL of condensed lipoaspirate
were connected to the Fractionator, a Luer to Luer transfer
with three 1.4 mm holes (Tulip) (Figure S2, Supporting
Information). Mechanical dissociation was performed by
pushing the lipoaspirate through the Fractionator forward
and backwards thirty times (Video S1, Supporting Informa-
tion). After mechanical dissociation, the adipose tissue was
centrifuged again at 3,000 rpm with a 9.5 cm radius fixed
angle rotor for 2.5 minutes at RT (Medilite). This resulted
in four different fractions: an oily fraction, a SVF (from
heron referred as “FAT-SVF”) and an aqueous fraction con-
taining a small pellet fraction (Figure 1).
Stromal vascular fraction viability
A live dead staining with Carboxyfluorescein Diacetate
Succinimidyl Ester (CFDA-SE) and Propidiumiodide (PI)
was performed to measure the FAT-SVF viability com-
pared to the control (n5 3). For CFDA-SE and PI staining,
prewarmed 0.001% of CFDA-SE and 0.001% of PI in
serum free Dulbecco’s Modified Eagle’s Medium
(DMEM) was used directly on the FAT-SVF and control.
After 30 minutes of incubation under culture conditions
cells were washed with phosphate buffered saline (PBS)
three times and fixed with 2% paraformaldehyde (PFA).
DAPI of 0.0002% in PBS was used to stain the nuclei. As
a dead cell control, a few samples were fixed with 2%
PFA in PBS and then stained with PI. Results were evalu-
ated with a confocal immunofluorescence microscope
(Leica TCS SP2 AOBS spectral confocal microscope,
Leica Microsystems, Buffalo Grove, IL).
Immunohistochemistry and Masson’s Trichrome
Four of the obtained samples of FAT-SVF and control
were formalin-fixed and embedded in paraffin. Four mm of
slides were deparaffinized and incubated overnight with
0.1 M Tris/HCL buffer (pH 9.0) for a-Smooth Muscle
Actin (a-SMA) and Perilipin A, von Willebrand Factor
(vWF) staining was preincubated with 10 mM Tris/1 mM
EDTA buffer (pH 9.0). Then, endogenous peroxidase
activity was blocked with 30% hydrogen peroxide in PBS
for 30 minutes RT. Samples were washed with PBS three
times and incubated with primary antibody and 1% bovine
serum albumin (BSA) in PBS for 1 hour RT. One percent
of human serum (HS) for a-SMA and Perilipin A and 1%
swine serum for vWF was added to the primary antibody
and 1% BSA. Negative controls were incubated without
primary antibodies. Subsequently all samples, including
negative controls, were washed with PBS three times and
Figure 1. The mechanical dissociation procedure results in
four different fractions: (1) oily fraction, (2) SVF and (3) infil-
tration fluid fraction containing (4) a small pellet fraction.
[Color figure can be viewed at wileyonlinelibrary.com]
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incubated with secondary antibody, 1% BSA, 1% HS in
PBS for 30 minutes RT. Only a third antibody in 1% BSA
and 1% HS in PBS for 30 minutes was used in a -SMA
staining. Staining was completed with 3,30-diaminobenzi-
dine incubation (Sigma Life Science, St. Louis, MO) and
hematoxylin staining of nuclei. Finally, samples were
mounted with aqueous mounting agent and visualized
under light microscope (Leica Microsystems, DM IL). A
Masson’s Trichrome staining was performed as well after
4 mm slides (n5 4) were deparaffinized. Samples were
mounted with toluene solution and visualized under light
microscope (Leica Microsystems, DM IL).
Primary antibodies used in this study were directed
against alpha smooth muscle actin (aSMA, 1 : 200,
Abcam, Cambridge, United Kingdom) to stain smooth
muscle cells, vWF (1 : 200, DAKO, Glostrup, Denmark)
and Perilipin A (1 : 200, Abcam) to stain adipocytes and.
Secondary antibodies used in this study were polyclonal
Rabbit anti-mouse for a –SMA (1 : 100, DAKO), poly-
clonal Swine anti-rabbit for vWF (1 : 100, DAKO) and
polyclonal Goat anti-rabbit (1 : 100, DAKO) for Perilipin
A. Third antibody used was polyclonal Swine anti-rabbit
(1 : 100, DAKO).
Cell isolation and culture
Ten of the obtained samples (FAT-SVF & control) were
washed with PBS three times. After washing, 0.1% colla-
genase A in PBS/1% BSA as dissociation medium was
added. The samples were stirred for 1.5 hour in a 378C
water bath. Cells were resuspended in lysisbuffer and
placed on ice for 5 minutes to disrupt erythrocytes. The
samples were centrifuged at 8 8C, 6003g for 10 minutes
and resuspended in DMEM (BioWhittaker Walkersville,
MD): 10% fetal bovine serum (FBS), 1% L-Glutamine, 1%
Penicillin/Streptomycin (P/S). Then, seeded in a 6-well
plate or 25 cm2 tissue culture flask depending on the
amount of cells. Cells were counted on staining with try-
pan blue in a B€urker Turk counting chamber. Cells were
cultured at 37 8C at 5% CO2 in a humidified incubator,
medium was refreshed twice a week. Morphology of the
cells derived from the FAT-SVF and control were com-
pared after 8 days of culture and visualized with an
inverted light microscope with Nomarski phase contrast
(Leica Microsystems, DM IL).
Flow cytometry
Cells (n5 6) collected from cultures after passage 2–4
were analyzed for CD surface marker expression using
flow cytometry. Cells were stained with two different sets
of anti-human monoclonal antibodies.
Subset A: CD31- phycoerythrine/cyanine7 (Pe/Cy7; IQ
Products, Groningen, The Netherlands), CD45-fluorescein
isothiocyanate (FITC; IQ Products) and CD90-
allophycocyanin (APC; BD Bioscience, San Jose, CA).
Subset B: CD29-APC (eBiosience, Vienna, Austria),
CD44-FITC (BD Bioscience) and CD105-Pe/Cy7 (eBio-
sience). As isotype controls, the following monoclonal
antibodies were used: Mouse IgG1 kappa-Pe/Cy7, Mouse
IgG1 kappa-APC (both eBioscience) and Mouse IgG1
kappa-FITC (Biolegend, San Diego, CA). Cells were
mixed well with each antibody and incubated on ice and
in dark for 30 minutes. Isotype cells were used to set the
gates on the basis of the staining. A BD FACScalibur sys-
tem was used to analyze the samples.
Adipogenic, osteogenic, and smooth muscle cell
differentiation assay
Cells from passage 2–4 (n5 6) were collected and cul-
tured in a 24-well plate and incubated in DMEM (con-
taining 10% FBS, 1% L-Glutamine and 1% P/S). After
reaching confluence, adipogenic, osteogenic and smooth
muscle cell differentiation medium was added to show
lipid accumulation, mineralization of bone-like noduli
and expression of filamentous actin (F-actin) respectively.
Adipogenic differentiation medium consisted of DMEM,
0.1 mM dexamethasone, 1 nM insulin, 0.5 mM isobuty-
methylxanthine. Osteogenic medium consisted of DMEM,
0.1 mM dexamethasone, 10 mM b-glycerophosphate and
0.05 mM ascorbic acid. Smooth muscle cell differentiation
medium consisted of DMEM and 0.1% TGF-beta1. Cells
Figure 2. Immunofluores-
cent images of FAT-SVF
and control viability. Living
cells turned green, while
dead cells turned red after
staining with CFDA-SE/PI.
Nuclei turned blue after
staining with DAPI. [Color
figure can be viewed at
wileyonlinelibrary.com]
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were cultured in differentiation medium for 14 days. Medi-
um was refreshed twice a week. After 14 days, cells were
fixed with 2% PFA and stained with Oil Red O (Sigma-
Aldrich, St. Louis, MO) for adipogenic differentiation,
Alizarin Red (Sigma Aldrich) for osteogenic differentiation
and Phalloidin-FITC (1 : 250, Invitrogen, Thermo Fisher
Scientific) in DAPI for 30 minutes for smooth muscle cell
differentiation. Oil Red O staining and Alizarin Red staining
Figure 3. (A) Light micro-
scope images of Mas-
son’s Trichrome, a-SMA,
vWF, and Perilipin A
staining of the FAT-SVF
and control samples. (B)
Statistic data of expres-
sion of a-SMA and vWF
in the FAT-SVF as well as




vessels were visible in
the FAT-SVF as compared
to the control (p<0.05).
**Significant more endo-
thelial cells visible in the
FAT-SVF compared to the
control (p<0.01). [Color
figure can be viewed at
wileyonlinelibrary.com]
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were evaluated with a light microscope (Leica Microsys-
tems, DM IL). Phalloidin-FITC staining was evaluated with
an immunofluorescence microscope (Leica Microcystems,
DM IL).
Colony formation assay
Hundred and thousand cells of FAT-SVF and control
(n5 3) were plated in a 6-well plate in triplicate and cul-
tured for 14 days. Cell culture plates were washed with
PBS three times and fixed with 2% PFA in PBS for 15
minutes. Cells were again washed with PBS three times
and stained with 0.05% Crystal Violet (Sigma-Aldrich).
After staining, cells were washed with tap water two times
and dried inverted. The cloning efficiency or capacity to
form colonies from single seeded cells was assessed by
determining the area of colonies as well as their intensity
of staining with Crystal Violet, both of which are surrogate
determinants for the number of cells. Colony area and
intensity were analyzed using a plugin for imageJ.23
Images were taken using Tissue FAXS microscope
(TissueGnostics, Vienna, Austria).
Statistical analysis
Immunohistochemistry images and colony formation assay
images were analyzed using ImageJ, version 1.4.3.67
(NIH). Descriptive statistics were used to evaluate the cell
numbers, a-SMA and vWF expression, CD surface expres-
sion scores and colony area and intensity. Data were
expressed as mean6 standard deviation. A t-test was per-
formed using Graphpad Prism, version 5.01 (Graph Pad
Software Inc., Los Angeles, CA).
RESULTS
Only living cells in the SVF
In the FAT-SVF as well as in the control, only living cells
(green) were detected (Figure 2) in contrast to the dead
cell (red) controls that contained only dead cells
(Figure S3, Supporting Information).
Immunohistochemistry and Masson’s Trichrome
The fraction of small vessels visible in FAT-SVF (deter-
mined as mean a-SMA positivity of 6.2%, [1/2 5.5]
and mean vWF positivity of 7.0%, [1/2 4.2]) was
higher than in the controls (mean a-SMA positivity
of 0.6%, [1/20.6] and mean vWF positivity of 0.3%,
[1/20.3]), respectively p< 0.05 and p< 0.01 (Figure 3).
Interestingly, in both groups, vessels were present that
did not express vWF. Likely, the procedure to generate
the FAT-SVF had activated part of the vessels and caused
these to release their vWF. vWF and other “damage-
response” proteins, are stored in the Weibel Palade bodies
within endothelial cells, the contents of which are secret-
ed after stress-induced activation such mechanical shear.
Therefore, only quantification of vWF was performed on
samples that expressed vWF staining, implying the pres-
ence of nonactivated EC. Perilipins are lipid-coating pro-
teins that protect against lipase action. Therefore, the
presence of Perilipin marks intact adipocytes. After
mechanical dissociation, adipocyte “ghosts” were present
in the FAT-SVF occasionally (Figure 3). Mainly large
adipocytes were visible in the control, whereas only
smaller ones in the FAT-SVF. Masson’s Trichrome stain-
ing showed more collagen deposition (blue) between the
cells (red) in the FAT-SVF as compared to the control
(Figure 3), implying enrichment of ECM in the FAT-SVF
by disrupting adipocytes compared to controls.
Mechanical dissociation cell yield
Complete mechanical dissociation of adipose tissue was
performed intraoperatively within 8 to 10 minutes of extra
operating time and resulted in a FAT-SVF with a mean
volume of 0.96 mL [range 0.75 to 1.75]. Enzymatic isola-
tion of the FAT-SVF resulted in a mean number of cells
of 2.7 3 106 [1/2 1.1 3 106] per 1 mL (Figure 4). Enzy-
matic isolation of 10 mL of the control resulted in a mean
number of cells of 3.5 3 105 [1/25.1 3 106] per 1 mL
(p< 0.001), a 7.7 times lower number of cells in 1 mL
adipose tissue as compared to 1 mL of FAT-SVF (Figure
4). Three patients were excluded from the study. One
patient had an uncountable low number of cells in the
FAT-SVF sample. In one FAT-SVF and one control sam-
ple of two different patients, we were unable to culture
enough cells to reach confluency. Cultured cells had a
spindle-shaped fibroblast-like morphology in both samples
(Figure S4, Supporting Information). There was no visible
difference between both groups.
Cells cultured from mechanically dissociated adipose
tissue harbor ASC characteristics
For subset A, a mean of 99.8% [1/20.2] of the FAT-SVF
































Figure 4. Statistic data of number of nucleated cells per
1 mL of FAT-SVF and control samples. Results are pre-
sented as mean6 standard deviation. *** FAT-SVF contains
significant more nucleated cells in 1 mL as compared to
1 mL of control (p<0.001).
van Dongen et al. FAT procedure for stromal vascular fractions
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and CD45 were shown. For the control, a mean of 99.8%
[1/2 0.1] showed expression of CD90 with also no
expressions of CD31 and CD45. There was no significant
difference between the two groups (p> 0.05).
For subset B, a mean of 99.8% [1/0.2], 99.0% [1/0.7]
and 95.9% [1/2 4.5] of the FAT-SVF showed expression
of CD29, CD44, and CD105. For the control, a mean of
98.2% [1/23.5], 98.5% [1/1.2] and 96.6% [1/2.6] showed
expression of CD29, CD44, and CD105, respectively. No
significant differences occurred between the two groups
(p> 0.05). Representative data of CD-surface marker
expression is shown in Figure S5, Supporting Information.
Cells cultured from FAT-SVF retain adipogenic,
osteogenic and smooth muscle cell differentiation
capacity
All samples of the FAT-SVF and the control showed sig-
nificant more lipid droplet formation, mineralized bone-
like noduli formation and f-actin expression compared to
their negative controls (Figure S6, Supporting Informa-
tion). No significant differences were present between the
FAT-SVF and the control (Figure 5). As ASC are known
to express F-actin in all cases, all negative controls were
slightly positive as anticipated. One sample of the control
group detached, most likely due to contraction of F-actin.
Cells from FAT-SVF retain colony formation capacity
Total colony areas and colony intensities did not
differ between ASC derived from the FAT-SVF and con-
trols. This was irrespective of the initial seeding density
(p> 0.05) (Figure 6).
DISCUSSION
In this study, we have demonstrated that the FAT proce-
dure is both efficient and reliable intra-operative method
to isolate the FAT-SVF from adipose tissue within 8 to 10
minutes in a simple and reproducible way, suitable for
Figure 5. Light microscope
and immunofluorescent
images of ASC derived
from FAT-SVF and control.
(A) After Oil Red O staining,
lipid droplet accumulation
turned red. (B) After Alizarin
Red staining, mineralized
bone-like nodules turned
red. (C) After phalloidin-FITC
staining, F-actin turned
green. No visual differences
between FAT-SVF and con-
trol. [Color figure can be
viewed at wileyonlinelibrary.
com]
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injection: the FAT procedure dissociates lipoaspirate by
disrupting adipocytes mechanically and consequently
results in a SVF containing culturable ASC as well as
small vessels embedded in an ECM. This FAT-SVF is
indicated to increase scar remodeling and might even
accelerate wound healing in vivo.
ASC derived from the FAT-SVF as well as ASC from
the control showed similar expression with regard to the
CD-surface markers, had similar like spindle shaped
fibroblast-like morphology, the same multipotent differen-
tiation potential and colony formation capacity.
Phenotypically, ASC have two main characteristics.
First, ASC possess markers such as mesenchymal markers
(CD291, CD441, CD901, and CD1051) and endothelial
and hematopoietic markers (CD312 and CD452, respec-
tively).24 ASC freshly isolated from adipose tissue are
CD1052, but become CD1051 after culturing.17 There-
fore, the variation of CD1051 cells can be larger than for
other CD surface markers. Furthermore, endothelial cells
also express CD105, which is TGF-beta receptor type III,
which might influence the FACS results.17 Second, ASC
are able to attach to culture plastic flasks and present as
having a spindle shaped fibroblast-like morphology. Func-
tionally, ASC are characterized by their ability to differen-
tiate into adipocytes, osteoblasts and smooth muscle
cells.12,24 As there are no significant or visual differences
in function and phenotype between ASC derived from the
SVF and the control, the FAT procedure apparently does
not affect the potential of ASC. Furthermore, the FAT pro-
cedure results in a FAT-SVF that contains only living cells
and significantly more nucleated cells in 1 mL of adipose
tissue as compared to nondissociated lipoaspirate.
The FAT procedure is a reproducible method to gener-
ate consistent volumes of injectable FAT-SVF. The com-
position of the FAT-SVF is histologically heterogeneous:
some parts consist of small blood vessels mainly, while
other parts consist of ECM only. We surmise that the
mechanical disruption of the adipose tissue causes a redis-
tribution of softer (ECM) and harder (microvasculature)
component of the FAT-SVF. The heterogeneity, however,
could also be a consequence of inter-patient variation. For
this study anonymized samples were obtained. Therefore,
future clinical trials might reveal variation among patients.
vWF staining was only present in the nonactivated endo-
thelial cells in the FAT-SVF. Activated endothelial cells
secrete their vWF and respond, therefore, negative to the
vWF staining. The ratio between activated and non-
activated endothelial cells, however, remains unclear.
Quantification of the number of adipocytes as compared to
the surface area of FAT-SVF proved methodologically to
be impossible. When all adipocytes are mechanically dis-
rupted, the FAT-SVF disintegrates into small unquantifi-
able parts. When a few adipocytes are still intact, bigger
parts of FAT-SVF are visible. In this way only quantifica-
tion of the bigger parts of FAT-SVF, containing more adi-
pocytes, is possible. So therefore, the number of
adipocytes counted is higher as compared to the real num-
ber of adipocytes. Interestingly, our method to disrupt adi-
pose tissue yielded an injectable FAT-SVF that contains
all the prerequisites for tissue regeneration: ASC, micro-
vasculature and supporting ECM.
Compared to conventional or automated dissociation
methods of adipose tissue, the FAT procedure is a faster
and more cost-effective method to produce a FAT-SVF.25
The dissociation device is small and of simple design, i.e.,
even in disposable format can be produced cost effective,
in particular in large quantities. The short time necessary
for the mechanical dissociation procedure enables the sur-
geon to use the FAT-SVF during surgery with a minimal
delay of operation time. It also likely contributes to the
high vitality of cells that are retained in the FAT-SVF. As
opposed to enzymatic digestion, where ASC need to sur-
vive in an ischemic environment due to the lengthy isola-
tion procedure. Also the use of collagenase or non-
autologous material potentially renders enzymatic digestion
more sensitive for (bacterial) contamination. Furthermore,
enzymatic isolation results in a SVF comprised of a sus-
pension of individual, nonconnected cells with a total lack
of tissue structure. In general, retention rates of single cell
injections (i.e., ASC) are rather low.26 With mechanical
dissociation, the ECM is retained in the FAT-SVF, which
probably functions as a “microvascularized” scaffold for
the ASC thus keeping a matrix for tissue integrity. In this
way, it can be expected to increase cell survival after
injection, thus reducing the otherwise low reported reten-
tion rates.
The interaction between cells and growth factors in
FAT-SVF is expected to increase the regenerative potential
in cell-based therapy as compared to the single use of
ASC. For instance, the combined application of pericytes
Figure 6. Statistic data of (A) total colony area covered and
(B) colony intensity of ASC derived from FAT-SVF and con-
trol. No significant differences in colony area covered and
intensity between ASC derived from FAT-SVF and control
when hundred or thousand cells were seeded (p>0.05).
van Dongen et al. FAT procedure for stromal vascular fractions
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and endothelial cells has been shown to augment angio-
genesis compared to their single use.27 Additionally, ASC
enhance angiogenesis through secreted growth factors such
as vascular endothelial growth factor (VEGF), fibroblast
growth factor(s) (FGF), and hepatocyte growth factor
(HGF),28,29 in particular under hypoxia.20 ASC conditioned
medium, which is rich in VEGF, FGFs, and HGF, both
increases the proliferation rate of endothelial cells, while
suppressing apoptosis, in particular under hypoxia.29 Endo-
thelial cell proliferation and survival are important mecha-
nisms in angiogenesis.30 Furthermore, the ECM in FAT-
SVF influences the migration and morphogenesis of angio-
genesis.31 ECM contains several proteins such as collagen
and fibronectin, which are important during the wound
healing process.32 Hence, we surmise that FAT-SVF might
also be a suitable cell-based therapy for stimulating wound
healing or regeneration of damaged tissue, as we already
have experienced in two illustrative cases (rest of series
will be published when the prospective clinical trials have
been finished). Firstly, a 62-year-old female patient suf-
fered for nine months from prolonged redness and scar for-
mation on her right cheek after a too deep peeling with
trichloroacetic acid (TCA) that did not want to subside.
Within 3 weeks after injection with 1 mL of FAT-SVF,
the deep red colored scar became brighter and turned into
nearly normal skin (Figure 7). In the second case, a 33-
year-old female patient received an injection of FAT-SVF
in the lateral 5 cm of the horizontal incision after a mam-
ma reduction. Two weeks postoperative, full dehiscence of
the wounds occurred, after cheese wiring of the barbed
suture, except for the area treated by FAT-SVT (Figure
7).33 Probably, FAT-SVF injection accelerated wound
healing, making the premature scar better resistant to
mechanical forces in an earlier phase during wound repair
compared to the nontreated wound edges.
Autologous adipose tissue transplantation to replace
lost volume or to improve wound healing and revise der-
mal scars, i.e., fibrotic lesions is routinely performed
nowadays. Ideally, anti-scar treatment would resolve the
existing scar which would involve the degradation of
excessively deposited ECM, the removal of unwanted cells
such as myofibroblasts and finally the restoration of the
original tissue architecture of the dermis including its sub-
cutaneous adipose tissue. We argue that initially the filler
Figure 7. (A) A 62-year-old
female patient with a nine-
month-old scar as a result
of a too deep TCA peeling.
After injection with FAT-
SVF, the dark red coloriza-
tion of the scar became
brighter and resembled to
normal skin. (B) A 33-year-
old female patient with par-
tial dehiscence of the
wounds, 2 weeks postoper-
ative after a mamma reduc-
tion. The lateral 5 cm of the
horizontal scar was injected
with FAT-SVF after the
mamma reduction and
remained closed. Barbed V-
lock suture is still intact and
visible in first image. Black
lines mark the place of the
suture in the second image.
[Color figure can be viewed
at wileyonlinelibrary.com]
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effect of fat grafts is less relevant than its anti-scarring
properties. Thus, enrichment of anti-scarring cells or
matrix, which are both present in the FAT-SVF, might
favor the process. At later stages, the precursor cells of
adipocytes that reside within FAT-SVF, will regenerate the
subcutaneous adipose tissue. Treatment of fibrosis in
organs such as heart, kidney or liver, or in osteoarthritic
joints such a knee or temporomandibular, with bulky lipo-
grafts is undesirable, due to tissue damage caused by injec-
tion of large volumes. Therefore, the reduction of the
volume of lipoaspirate, as can be achieved with our FAT
procedure, to generate an injectable ECM-based cellular-
ized therapeutic gel, that act as an instructive scaffold for
repair, seems to be a promising alternative.
CONCLUSION
The FAT procedure is an effective method to mechanically
dissociate lipoaspirate and to create a FAT-SVF with all
the therapeutic components of adipose tissue in about 10%
of its original volume during a surgical procedure without
hardly any time-loss: it contains a 7.7 times higher number
of nucleated cells as compared to nondissociated lipoaspi-
rate and ASC embedded in an ECM that also contains a
microvasculature structure.
Further prospective studies are necessary to assess the
therapeutic value of the FAT-SVF as such, for e.g., in
organ repair, scar revision, osteoarthritis, or wound heal-
ing. Currently, we are conducting two double blind ran-
domized clinical trials to assess this effect of FAT-SVF on
scar formation and skin quality.
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